Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Recruiting · NCT05571735 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients | Actinomycetales infectious disease, Bacterial Infections and Mycoses, COVID-19, COVID-19 Pandemic, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, tuberculosis, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-04-13 | NCT05571735 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Oxford | 213 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shoklo Malaria Research Unit (SMRU) | Mae Ramat | Thailand | 1 |